An aberrant activation of IL6/JAK/STAT3 and tofacitinib gene signatures was found in biopsies from SSc patients and Tofacitinib was reported to be effective in preventing bleomycin-induced skin and lung fibrosis in the animal models. The gene discussed is STAT3; the disease is pulmonary fibrosis.